Ignite Creation Date:
2024-10-25 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06583330
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-01
Brief Title:
A Multicenter Open-Label Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicenter Open-Label Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
research objective
1 Optimize VTE prevention management after CRC surgery
2 Improve the prevention and treatment level of VTE in current perioperative patients
3 Reduce the social burden of VTE related diseases
Participants will
1 start low molecular weight heparin prophylaxis within 24 hours post-surgery
2 The prophylactic regimen for the experimental group lasted 14 days while the control group received it for 28 days Low molecular weight heparin is given subcutaneously at a dose of 03ml once daily
3 atients underwent lower limb color Doppler ultrasound on postoperative days 7 2 14 3 and 28 5 which included screening for thrombosis in the proximal deep veins femoral popliteal distal deep veins posterior tibial fibular and muscular veins and their perforating branches
1 Optimize VTE prevention management after CRC surgery
2 Improve the prevention and treatment level of VTE in current perioperative patients
3 Reduce the social burden of VTE related diseases
Participants will
1 start low molecular weight heparin prophylaxis within 24 hours post-surgery
2 The prophylactic regimen for the experimental group lasted 14 days while the control group received it for 28 days Low molecular weight heparin is given subcutaneously at a dose of 03ml once daily
3 atients underwent lower limb color Doppler ultrasound on postoperative days 7 2 14 3 and 28 5 which included screening for thrombosis in the proximal deep veins femoral popliteal distal deep veins posterior tibial fibular and muscular veins and their perforating branches
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None